Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling

Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling

British Journal of Cancer 116, 1302 (9 May 2017). doi:10.1038/bjc.2017.89

Authors: Sheng Han, Lingxuan Meng, Yang Jiang, Wen Cheng, Xinxin Tie, Junzhe Xia & Anhua Wu

http://ift.tt/2onne4v